| CAS: | 724741-75-7 | ||
| 分子式: | C23H25N3O3S | ||
| 分子量: | 423.53 | ||
| 英文名称: |
| ||
| 用途: | STF-31是一种选择性葡萄糖转运蛋白GLUT1抑制剂。STF-31特异性靶向作用于通过GLUT1的葡萄糖摄取,从而选择性杀死RCCs。STF-31显著抑制VHL-缺失细胞中60%的乳酸产生和胞外酸化,并通过减少葡萄糖转运减少糖酵解。[1]在表达NAPRT1的细胞中,STF-31通过抑制NAMPT酶活性表现出细胞毒性。[2] STF-31对hPSCs是有毒的,并且足以从混合的培养物中选择性清除hPSCs。[3] |
| 货号 | 品牌 | 产品名称 | 规格 | 包装、参考价格 | |||||||||||||||||||||||||||||||||||||||||||||||
| S793659 | MACKLIN | STF-31 | 10mM in DMSO | 516元/1ml; | 咨询 | ||||||||||||||||||||||||||||||||||||||||||||||
储存:-20°C | |||||||||||||||||||||||||||||||||||||||||||||||||||
| S872879 | MACKLIN | STF-31 | 99% | 375元/5mg; 1211元/25mg; | 咨询 | ||||||||||||||||||||||||||||||||||||||||||||||
储存:-20℃ 状态:白色到米黄色粉末 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| SML1108 | Sigma-Aldrich | STF-31 | ≥98% (HPLC) | 1399.43元/5 MG; 5643.95元/25 MG; | 咨询 | ||||||||||||||||||||||||||||||||||||||||||||||
产品说明 应用 STF-31 has been used in glucose transporter 1 (GLUT1) inhibition. 包装 5, 25 mg in glass bottle 生化/生理作用 STF-31 selectively inhibits the glucose transporter GLUT1 and selectively impairs cancer cell growth of kidney and other types of cancer cells that lack the von Hippel-Lindau (VHL) tumor suppressor protein. Inactivation of VHL increases the activity of hypoxia-inducible factor transcription factor HIF, which in turn stimulates the transcription of genes involved in glucose metabolism, including the GLUT1 gene. VHL-deficient cancer cells, which include about 80% of renal cell carcinomas, are dependent on the high affinity GLUT1 transporter and aerobic glycolysis for ATP production. STF-31 binds directly to the GLUT1 transporter, blocking glucose uptake, resulting in necrosis in VHL-deficient cancer cells, but not in normal cells or cancer cells with intact VHL. 特点和优势 This compound is a featured product for Gene Regulation research. Click here to discover more featured Gene Regulation products. Learn more about bioactive small molecules for other areas of research at sigma.com/discover-bsm. 基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||||||||||||||||||||||||||